PDS Planning Inc Raises Stock Holdings in Danaher Corporation $DHR

PDS Planning Inc boosted its holdings in shares of Danaher Corporation (NYSE:DHR) by 11.1% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,207 shares of the conglomerate’s stock after purchasing an additional 420 shares during the quarter. PDS Planning Inc’s holdings in Danaher were worth $831,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in DHR. GAMMA Investing LLC raised its holdings in shares of Danaher by 22.2% during the first quarter. GAMMA Investing LLC now owns 9,126 shares of the conglomerate’s stock valued at $1,871,000 after acquiring an additional 1,660 shares during the last quarter. Assenagon Asset Management S.A. raised its holdings in shares of Danaher by 1.0% during the first quarter. Assenagon Asset Management S.A. now owns 20,634 shares of the conglomerate’s stock valued at $4,230,000 after acquiring an additional 203 shares during the last quarter. CX Institutional raised its holdings in shares of Danaher by 11.2% during the first quarter. CX Institutional now owns 3,304 shares of the conglomerate’s stock valued at $677,000 after acquiring an additional 334 shares during the last quarter. Zhang Financial LLC raised its holdings in shares of Danaher by 3.6% during the first quarter. Zhang Financial LLC now owns 1,774 shares of the conglomerate’s stock valued at $364,000 after acquiring an additional 62 shares during the last quarter. Finally, Baker Chad R raised its holdings in shares of Danaher by 7.1% during the first quarter. Baker Chad R now owns 68,665 shares of the conglomerate’s stock valued at $14,076,000 after acquiring an additional 4,545 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insider Buying and Selling at Danaher

In other news, Director Teri List sold 2,778 shares of Danaher stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the sale, the director directly owned 20,751 shares of the company’s stock, valued at approximately $4,379,706.06. The trade was a 11.81% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Insiders own 11.10% of the company’s stock.

Danaher Price Performance

DHR stock opened at $202.53 on Friday. The business has a fifty day moving average of $200.66 and a two-hundred day moving average of $197.25. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. The stock has a market cap of $145.02 billion, a price-to-earnings ratio of 43.09, a price-to-earnings-growth ratio of 2.91 and a beta of 0.77. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $279.41.

Danaher (NYSE:DHR) last posted its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.64 by $0.16. The company had revenue of $5.94 billion during the quarter, compared to analysts’ expectations of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The firm’s quarterly revenue was up 3.4% compared to the same quarter last year. During the same quarter last year, the firm earned $1.72 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, research analysts anticipate that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be paid a $0.32 dividend. The ex-dividend date of this dividend is Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. Danaher’s payout ratio is presently 27.23%.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the company. Barclays reissued an “overweight” rating and set a $225.00 target price (up previously from $215.00) on shares of Danaher in a report on Tuesday, June 24th. Evercore ISI increased their price target on Danaher from $226.00 to $245.00 and gave the company an “outperform” rating in a report on Tuesday. UBS Group cut their price target on Danaher from $240.00 to $225.00 and set a “buy” rating for the company in a report on Wednesday, July 23rd. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Danaher in a report on Wednesday. Finally, Rothschild Redb cut Danaher from a “strong-buy” rating to a “hold” rating in a report on Wednesday. Seventeen analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $244.60.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.